4Kiefel V, Konig C, Kroll H, et al. Platelet alloantibodies in trans- fused patients. Transfusion ,2001,41 (6) :766-770.
5METCALFE P, WATKINS N A, OU3YCEHAND W H, et al. Nomenclature of hunan platelet antigens[J]. Vox Sang, 2003, 85: 240.
6SCHIFFER C A, ANDERSON K C, BENNETT C. Clinical practice guidelines of the American Society of Clinical Oncology[ J ]. J Clin Oncol, 2001, 19:1 519- 1 538.
7CROW A R, FREEDMAN J, HANNACH B, et al. Antibody - mediated inhibition of the human alloimmune response to platelet transfusion in Hu - PBL - SCID mice [ J ]. Br J Haematol, 1999, 104(4) : 919 -924.
8SANZ C, FREIRE C, ALCORTA 1, et al. Pateletspecific ant ibodies in HLA - immunized patients receiving chronic platelet support[J]. Transfusion, 2001, 41(6): 762-765.
9SEFrEL M D, GROWE G H, PETRASZKO T, et al. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness [ J ]. Blood, 2004, 103 ( 1 ) :333 - 339.
10SATO S, SAKURAI T, YAMAMOTO Y, et al. Earlier detection of HLA alloimmunization in platelet tyansfusion refractoyiness by flow cytometric analysis[ J ]. Tyansfusion, 2005, 45 (8) : 1 399 - 1 401.
